Can the SpotOn™ Zero-Heat-Flux-Thermometry Sensor Accurately Measure Core Temperature in Children?

NCT ID: NCT03157609

Last Updated: 2025-11-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-11-15

Study Completion Date

2018-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The present study aims to assess the accuracy of the SpotOn™ Zero-heat-flux-thermometry sensor in measuring core temperature in the paediatric population in the perioperative period.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Temperature regulation in the perioperative period is of primordial importance in paediatric population - a particularly sensitive group for thermal variations.

In fact, infants lose a significantly high percentage of their core heat from skin perspiration in comparison to adults (where it approximates roughly 10%). This percentage can go up to 20% in premature infants and relates to the fact that cutaneous heat loss is "grosso modo" proportional to body surface area.

This higher thermal vulnerability is aggravated during the perioperative period, where body exposure to the cold operating room environment is increased, and where anaesthetic interventions impair the compensatory mechanisms to the extent of being unable to sufficiently increase heat production to compensate for hypothermia.

An alternative thermometry method called Zero-heat-flux was developed in the 1970's in an attempt to compensate for the limitations of pure skin temperature, while maintaining its practical character. It is based on the principle that the temperature 1-2 cm below skin surface reasonably approximates core temperature. In order to measure it, it uses 4-layered probe, with the following inside-out structure: patient temperature thermistor, insulating foam layer, heating (flex) circuit, and insulating foam. A servo-controlled system actively warms the probe circuit to the point where, theoretically, temperature equilibrium is achieved between the skin and deeper structures and there is zero heat transfer to the surrounding areas. This concept is commonly exemplified as the creation of a vertical isothermal tunnel between the skin surface and lower dermal layers. Assuming a good tissue perfusion, dermal temperature will reasonably approximate core temperature.

Although a systematic adult population validation is on its way, no data on the paediatric patients exists.

Considering the practical and non-invasive character of this skin surface probe, as well as the abovementioned thermal sensitivity concerns on the paediatric population, it seems that, should the probe indeed prove to be accurate in this age range, it can definitely contribute to the improvement of the perioperative temperature management in children.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypothermia; Anesthesia Hypothermia Following Anesthesia Children

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

OTHER

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors
use of a third person (blinded to study design, population and statistics) which will extract data blindly from the hospital anaesthesia electronic database

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Thermometry with SpotOn

Application of SpotOn sensor on forehead.

Group Type EXPERIMENTAL

Thermometry

Intervention Type DEVICE

Within the same patient comparison of 2 thermometry methods: SpotOn skin sensor versus oesophageal temperature probe

Thermometry with oesophageal probe

Nasal insertion of oesophageal temperature probe in the lower fourth of the oesophagus.

Group Type ACTIVE_COMPARATOR

Thermometry

Intervention Type DEVICE

Within the same patient comparison of 2 thermometry methods: SpotOn skin sensor versus oesophageal temperature probe

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Thermometry

Within the same patient comparison of 2 thermometry methods: SpotOn skin sensor versus oesophageal temperature probe

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ASA I \& II
* Age: 1d - 16 years
* Elective surgery
* Minimum anaesthesia time of 30 minutes

Exclusion Criteria

* Fragile skin state in the forehead
* Know allergy to probe adhesive
* Maxillofacial trauma or lesions
* Procedures impeding proper use of SpotOn™ sensor (mostly maxillo-facial)
* Abnormal oesophageal anatomy/gastroesophageal procedures.
* Coagulopathy
* Neurologically impaired children with abnormal thermoregulation
* Extensive Haemodynamic instability
* Need for Vasopression
* Procedures associated with extended use of rinsing fluids (abdominal/thoracic lavages)
* Thoracoscopic/thoracotomic procedures (oesophageal probe cooling)
* Need for use of "over body" forced air warming systems
* Malignant Hyperthermia or family history of malignant hyperthermia
* Fever / Infectious patient
* All conditions that might be judged to alter skin perfusion in an abnormal way
* Anatomical variants (overt hydrocephalus …)
* Calibration/device failure
Minimum Eligible Age

1 Day

Maximum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universitair Ziekenhuis Brussel

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hugo Carvalho, MD

Role: PRINCIPAL_INVESTIGATOR

Universitair Ziekenhuis Brussel

Nadia Najafi, MD

Role: STUDY_CHAIR

Universitair Ziekenhuis Brussel

Jan Poelaert, PhDMD

Role: STUDY_DIRECTOR

Universitair Ziekenhuis Brussel

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Universitair Ziekenhuis Brussel

Jette, Vlaams-Brabant, Belgium

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SpotOn v 1.0

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.